Nippon Life Global Investors Americas, Inc. Eli Lilly & CO Transaction History
Nippon Life Global Investors Americas, Inc.
- $1.98 Billion
- Q1 2025
A detailed history of Nippon Life Global Investors Americas, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Nippon Life Global Investors Americas, Inc. holds 69,790 shares of LLY stock, worth $44.3 Million. This represents 2.91% of its overall portfolio holdings.
Number of Shares
69,790
Previous 64,610
8.02%
Holding current value
$44.3 Million
Previous $49.9 Million
15.56%
% of portfolio
2.91%
Previous 2.35%
Shares
10 transactions
Others Institutions Holding LLY
# of Institutions
4,396Shares Held
755MCall Options Held
10.3MPut Options Held
10.9M-
Lilly Endowment Inc Indianapolis, IN96MShares$61 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$51.1 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$41.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$32.6 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.4MShares$21.9 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $604B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...